Cas no 30131-19-2 (4-Methyl-1-2-(4-piperidinyl)ethylpiperidinedihydrochloride)
4-Methyl-1-2-(4-piperidinyl)ethylpiperidinedihydrochloride Chemical and Physical Properties
Names and Identifiers
-
- 4-Methyl-1-[2-(4-piperidinyl)ethyl]piperidine dihydrochloride
- 30131-19-2
- 4-methyl-1-(2-piperidin-4-ylethyl)piperidine;dihydrochloride
- 4-Methyl-1-(2-(piperidin-4-yl)ethyl)piperidine dihydrochloride
- 4-Methyl-1-(2-(piperidin-4-yl)ethyl)piperidinedihydrochloride
- AKOS015845461
- 4-Methyl-1-[2-(4-piperidinyl)ethyl]piperidinedihydrochloride
- 4-Methyl-1-2-(4-piperidinyl)ethylpiperidinedihydrochloride
-
- MDL: MFCD13561671
- Inchi: 1S/C13H26N2.2ClH/c1-12-4-9-15(10-5-12)11-6-13-2-7-14-8-3-13;;/h12-14H,2-11H2,1H3;2*1H
- InChI Key: PFOOZWOMEMODDV-UHFFFAOYSA-N
- SMILES: Cl.Cl.N1(CCC(C)CC1)CCC1CCNCC1
Computed Properties
- Exact Mass: 282.1629543g/mol
- Monoisotopic Mass: 282.1629543g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 17
- Rotatable Bond Count: 3
- Complexity: 167
- Covalently-Bonded Unit Count: 3
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 15.3?2
4-Methyl-1-2-(4-piperidinyl)ethylpiperidinedihydrochloride Security Information
- HazardClass:IRRITANT
4-Methyl-1-2-(4-piperidinyl)ethylpiperidinedihydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | M042085-250mg |
4-Methyl-1-[2-(4-piperidinyl)ethyl]piperidinedihydrochloride |
30131-19-2 | 250mg |
$ 185.00 | 2022-06-04 | ||
| TRC | M042085-500mg |
4-Methyl-1-[2-(4-piperidinyl)ethyl]piperidinedihydrochloride |
30131-19-2 | 500mg |
$ 300.00 | 2022-06-04 | ||
| TRC | M042085-1000mg |
4-Methyl-1-[2-(4-piperidinyl)ethyl]piperidinedihydrochloride |
30131-19-2 | 1g |
$ 480.00 | 2022-06-04 | ||
| Chemenu | CM307330-1g |
4-Methyl-1-(2-(piperidin-4-yl)ethyl)piperidine dihydrochloride |
30131-19-2 | 95% | 1g |
$167 | 2022-09-01 | |
| Chemenu | CM307330-5g |
4-Methyl-1-(2-(piperidin-4-yl)ethyl)piperidine dihydrochloride |
30131-19-2 | 95% | 5g |
$500 | 2022-09-01 |
4-Methyl-1-2-(4-piperidinyl)ethylpiperidinedihydrochloride Related Literature
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
-
Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
Additional information on 4-Methyl-1-2-(4-piperidinyl)ethylpiperidinedihydrochloride
Comprehensive Overview of 4-Methyl-1-2-(4-piperidinyl)ethylpiperidine Dihydrochloride (CAS No. 30131-19-2)
4-Methyl-1-2-(4-piperidinyl)ethylpiperidine dihydrochloride (CAS No. 30131-19-2) is a chemically significant compound widely utilized in pharmaceutical research and development. This piperidine derivative has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. Researchers often explore its role as an intermediate in synthesizing bioactive molecules, particularly those targeting neurological and cardiovascular systems. The compound's dihydrochloride salt form enhances its solubility, making it more suitable for experimental and formulation studies.
In recent years, the demand for specialized piperidine derivatives like 4-Methyl-1-2-(4-piperidinyl)ethylpiperidine dihydrochloride has surged, driven by advancements in drug discovery. Users frequently search for terms such as "piperidine-based compounds in drug design" or "CAS 30131-19-2 applications," reflecting growing interest in its pharmacological potential. The compound's methyl and piperidinyl groups contribute to its versatility, enabling modifications for improved bioavailability and target specificity. Its relevance in addressing modern health challenges, such as neurodegenerative disorders, aligns with current scientific trends.
The synthesis and characterization of 4-Methyl-1-2-(4-piperidinyl)ethylpiperidine dihydrochloride involve meticulous processes to ensure purity and stability. Analytical techniques like HPLC and NMR spectroscopy are commonly employed to validate its structure. Researchers also investigate its metabolic pathways and interaction mechanisms, topics frequently queried in academic and industrial databases. The compound's dihydrochloride form is particularly noted for its compatibility with aqueous systems, a critical factor in preclinical studies.
From an industrial perspective, CAS 30131-19-2 is often discussed in contexts like "high-value chemical intermediates" or "scalable synthesis of piperidine derivatives." Its role in optimizing drug delivery systems, such as nanoparticle formulations, further underscores its importance. As the pharmaceutical sector shifts toward personalized medicine, compounds like 4-Methyl-1-2-(4-piperidinyl)ethylpiperidine dihydrochloride are pivotal in developing tailored therapies. This aligns with search trends emphasizing "precision medicine chemicals" and "innovative pharmaceutical intermediates."
Safety and regulatory compliance are paramount when handling 4-Methyl-1-2-(4-piperidinyl)ethylpiperidine dihydrochloride. While not classified as hazardous, proper storage conditions—such as controlled temperature and moisture-free environments—are recommended to maintain its integrity. The compound's stability profile and compatibility with excipients are frequently studied to ensure its suitability for long-term research applications. These aspects resonate with queries like "best practices for storing piperidine derivatives" or "CAS 30131-19-2 safety data."
In conclusion, 4-Methyl-1-2-(4-piperidinyl)ethylpiperidine dihydrochloride (CAS No. 30131-19-2) represents a critical asset in modern pharmaceutical science. Its structural features and adaptability make it a focal point for innovations in drug development. As research continues to explore its full potential, this compound is poised to remain a subject of significant scientific and industrial interest, addressing both current and emerging health challenges.
30131-19-2 (4-Methyl-1-2-(4-piperidinyl)ethylpiperidinedihydrochloride) Related Products
- 7149-42-0((1-methylpiperidin-4-yl)methanamine)
- 25549-16-0(Triisoctylamine)
- 65017-57-4(4-(Aminomethyl)-1-(n-butyl)piperidine)
- 14446-76-5(Piperidine,1,3,5-trimethyl-, (3R,5S)-rel-)
- 100-76-5(Quinuclidine)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)